Listed

Protalix BioTherapeutics, Inc.: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Mar 12, 2015 and accepted by EDGAR at Mar 12, 2015, 16:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2014-01-01 to 2014-12-31$13.7mus-gaap:Revenues
Cost of revenue12 months2014-01-01 to 2014-12-31$9.1mus-gaap:CostOfRevenue
Gross profit12 months2014-01-01 to 2014-12-31$6.1mus-gaap:GrossProfit
Research and development12 months2014-01-01 to 2014-12-31$29.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2014-01-01 to 2014-12-31$9.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2014-01-01 to 2014-12-31−$25.2mus-gaap:OperatingIncomeLoss
Interest expense12 months2014-01-01 to 2014-12-31$3.5mus-gaap:InterestExpense
Net income12 months2014-01-01 to 2014-12-31−$29.9mus-gaap:NetIncomeLoss
Diluted EPS12 months2014-01-01 to 2014-12-31−$0.32us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure12 months2014-01-01 to 2014-12-31$785.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-12-31$54.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$65.5mus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$78.5mus-gaap:Assets
Current liabilitiesAt period end2014-12-31$26.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-12-31$134.1mus-gaap:Liabilities
Long-term debtAt period end2014-12-31$912.0kus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2014-12-31−$55.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-15-015672. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.